LifeMD Pref A
LFMDP
LifeMD Pref A (LFMDP) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.16
- EPS estimate
- −$0.15
- EPS surprise
- −9.81%
- Revenue surprise
- −3.78%
- Revenue
- $47.3M
- Revenue estimate
- $49.2M
- Reported
- Aug 5, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | −$0.15 | −$0.16 | −9.81% | $47.3M | SEC |
| Q1 2026 | May 6, 2026 | −$0.21 | −$0.20 | +2.77% | $50.2M | SEC |
| Q4 2025 | Mar 9, 2026 | −$0.07 | $0.41 | +724.05% | $46.9M | SEC |
| Q3 2025 | Nov 17, 2025 | −$0.02 | −$0.10 | −400.00% | $60.2M | SEC |
| Q2 2025 | Aug 5, 2025 | −$0.01 | −$0.06 | −622.89% | $62.2M | SEC |
| Q1 2025 | May 6, 2025 | −$0.05 | $0.01 | +118.90% | $65.7M | SEC |
| Q4 2024 | Mar 10, 2025 | −$0.05 | −$0.02 | +61.09% | $64.3M | SEC |
| Q3 2024 | Nov 7, 2024 | −$0.12 | −$0.14 | −18.34% | $53.4M | SEC |
| Q2 2024 | Aug 7, 2024 | −$0.14 | −$0.19 | −31.94% | $50.7M | SEC |
| Q1 2024 | May 8, 2024 | −$0.15 | −$0.19 | −23.38% | $44.1M | SEC |
| Q4 2023 | Mar 11, 2024 | −$0.14 | −$0.12 | +14.29% | $44.9M | SEC |
| Q3 2023 | Nov 8, 2023 | −$0.09 | −$0.20 | −130.68% | $38.6M | SEC |
| Q2 2023 | Aug 9, 2023 | −$0.10 | $0.05 | +152.63% | $35.9M | SEC |
| Q1 2023 | May 12, 2023 | −$0.16 | $0.06 | +137.50% | $33.1M | SEC |
| Q4 2022 | Mar 22, 2023 | −$0.18 | −$0.40 | −122.22% | $28.1M | SEC |
| Q3 2022 | Nov 10, 2022 | −$0.21 | −$0.03 | +85.71% | $31.4M | — |
| Q2 2022 | Aug 11, 2022 | −$0.28 | −$0.22 | +21.43% | $30.5M | — |
| Q1 2022 | May 13, 2022 | −$0.29 | −$0.25 | +13.79% | $29.0M | — |
| Q4 2021 | Mar 7, 2022 | −$0.38 | −$0.29 | +22.67% | $27.4M | — |
| Q3 2021 | Nov 10, 2021 | −$0.56 | −$0.36 | +35.14% | $24.9M | — |
Quarterly revenue
Frequently asked questions
When did LifeMD Pref A (LFMDP) last report earnings?
LifeMD Pref A last reported on Aug 5, 2026, covering fiscal Q2 2026.
Did LFMDP beat earnings estimates?
No. LifeMD Pref A reported EPS of −$0.16 for Q2 2026 against a −$0.15 estimate — a 9.81% miss.
How much revenue did LFMDP report last quarter?
LifeMD Pref A reported $47.3M in revenue for Q2 2026, against a consensus estimate of $49.2M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.